Since biological processes occur at the nanoscale, the potential for using nanotechnology to develop new diagnostics and therapeutics for cancer is vast. For example, nanoparticles capable of exclusively targeting tumor cells and not harming healthy cells would dramatically reduce unwanted side effects. Such nanoparticle drug delivery systems could also allow clinicians to resurrect powerful chemotherapeutic agents that were abandoned due to their high toxicity.
In order to engage and inform the clinical community about recent advances at the convergence of nanotechnology and cancer, the IIN in partnership with the Robert H. Lurie Comprehensive Cancer Center and Baxter Healthcare Corporation sponsors an annual Nano Boot Camp for Clinicians.
This half-day symposium provides an excellent way for clinicians and medical students to gain an understanding of nanotechnology, the current advances in the field, and the prospects for translating these advances to the clinic.
The Nano Boot Camp for Clinicians is offered free of charge and is open to any interested clinician or student. It is generally held on Northwestern's Chicago campus in late fall.
For information about the next Nano Boot Camp for Clinicians, please click here.
Sign up for our newsletter to receive information on events, news, and articles.